Whether inhibiting P2Y12 would be beneficial in other neurological conditions, such as multiple sclerosis, Alzheimer’s or Parkinson’s disease, all of which are characterized by substantial pro-inflammatory responses, including microglial activation and ATP release, remains to be seen. This evidence concerns the gene P2RY12 and multiple sclerosis.